
Maravai LifeSciences Holdings, Inc.
NASDAQ:MRVI
2.61 (USD) • At close March 12, 2025
Overzicht | Financiële gegevens
Bedrijfsnaam | Maravai LifeSciences Holdings, Inc. |
Symbool | MRVI |
Munteenheid | USD |
Prijs | 2.61 |
Beurswaarde | 370,212,840 |
Dividendpercentage | 0% |
52-weken bereik | 2.595 - 11.555 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Mr. Carl W. Hull |
Website | https://www.maravai.com |
An error occurred while fetching data.
Over Maravai LifeSciences Holdings, Inc.
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for diagnostic and therapeutic
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)